Chris Braumann

1.6k total citations
97 papers, 1.1k citations indexed

About

Chris Braumann is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chris Braumann has authored 97 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Surgery, 43 papers in Oncology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chris Braumann's work include Pancreatic and Hepatic Oncology Research (23 papers), Neuroendocrine Tumor Research Advances (11 papers) and Esophageal and GI Pathology (11 papers). Chris Braumann is often cited by papers focused on Pancreatic and Hepatic Oncology Research (23 papers), Neuroendocrine Tumor Research Advances (11 papers) and Esophageal and GI Pathology (11 papers). Chris Braumann collaborates with scholars based in Germany, United States and Switzerland. Chris Braumann's co-authors include Christoph A. Jacobi, Charalambos Menenakos, C. A. Jacobi, Waldemar Uhl, Joachim Mueller, Andreas Minh Luu, Jens C. Rueckert, Jens Hartmann, N. Guenther and W. Schwenk and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Chris Braumann

96 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chris Braumann Germany 19 599 367 260 165 110 97 1.1k
Guido Grass Germany 17 342 0.6× 181 0.5× 238 0.9× 158 1.0× 100 0.9× 27 841
Kil Yeon Lee South Korea 19 786 1.3× 711 1.9× 163 0.6× 268 1.6× 43 0.4× 72 1.4k
Ching‐Chuan Hsieh Taiwan 23 312 0.5× 387 1.1× 225 0.9× 284 1.7× 26 0.2× 58 1.5k
Cem Terzi Türkiye 20 774 1.3× 554 1.5× 316 1.2× 142 0.9× 25 0.2× 60 1.2k
Masashi Tsuruta Japan 21 476 0.8× 709 1.9× 349 1.3× 284 1.7× 30 0.3× 73 1.5k
Arnulf Thiede Germany 20 872 1.5× 281 0.8× 407 1.6× 210 1.3× 158 1.4× 68 1.5k
Jianglong Huang China 15 415 0.7× 194 0.5× 168 0.6× 147 0.9× 45 0.4× 54 897
İbrahi̇m Koral Önal Türkiye 15 396 0.7× 140 0.4× 144 0.6× 57 0.3× 123 1.1× 56 803
Hee Seok Moon South Korea 20 562 0.9× 268 0.7× 477 1.8× 201 1.2× 360 3.3× 155 1.4k
Francesco Guerra Italy 18 467 0.8× 408 1.1× 259 1.0× 169 1.0× 55 0.5× 72 889

Countries citing papers authored by Chris Braumann

Since Specialization
Citations

This map shows the geographic impact of Chris Braumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Braumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Braumann more than expected).

Fields of papers citing papers by Chris Braumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Braumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Braumann. The network helps show where Chris Braumann may publish in the future.

Co-authorship network of co-authors of Chris Braumann

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Braumann. A scholar is included among the top collaborators of Chris Braumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Braumann. Chris Braumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Strotmann, Jörg, et al.. (2023). Oxathiazinane derivatives display both antineoplastic and antibacterial activity: a structure activity study. Journal of Cancer Research and Clinical Oncology. 149(11). 9071–9083. 1 indexed citations
2.
Schmitz, Lutz, Chris Braumann, Waldemar Uhl, et al.. (2023). An In Vitro Pilot Study Investigating the Antineoplastic Effects of GP-2250 on Cutaneous Squamous Cell Carcinoma Cell Lines: Preliminary Results. SHILAP Revista de lepidopterología. 3(1). 85–96. 1 indexed citations
3.
Hahn, Stephan A., et al.. (2023). GP‐2250, a novel anticancer agent, inhibits the energy metabolism, activates AMP‐Kinase and impairs the NF‐kB pathway in pancreatic cancer cells. Journal of Cellular and Molecular Medicine. 27(14). 2082–2092. 4 indexed citations
4.
Swanson, Terry, et al.. (2020). Ultrasonic-assisted wound debridement: report from a closed panel meeting. Journal of Wound Care. 29(2). 128–135. 10 indexed citations
5.
Braumann, Chris, et al.. (2018). Riddle Me This: Acalculous Cholecystitis as an Unusual Complication of Immunoglobulin M Negative Mononucleosis. Cureus. 10(4). e2505–e2505. 3 indexed citations
6.
Künzli, Beat, et al.. (2018). Tuberculosis Mimicking Disseminated Peritoneal Carcinomatosis of a Sigmoid Carcinoma. Journal of Gastrointestinal Surgery. 23(4). 877–878. 2 indexed citations
7.
Tannapfel, Andrea, et al.. (2017). Acinar Cell Cystadenoma - a Rarity in Advanced von Hippel-Lindau Disease: A Case Report. Visceral Medicine. 34(1). 73–75. 4 indexed citations
8.
Buchholz, Malte, Stephan A. Hahn, Deepak Vangala, et al.. (2017). Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivo. BMC Cancer. 17(1). 216–216. 13 indexed citations
9.
Braumann, Chris, et al.. (2016). Quality of life and need for care in patients with an ostomy: a survey of 2647 patients of the Berlin OStomy-Study (BOSS). Langenbeck s Archives of Surgery. 401(8). 1191–1201. 22 indexed citations
10.
Tsilimparis, Nikolaos, et al.. (2009). Malignant Melanoma Metastasis as a Cause of Small-Bowel Perforation. Onkologie. 32(6). 356–358. 11 indexed citations
11.
Braumann, Chris, et al.. (2008). Wound Healing Is Not Impaired in Rats Undergoing Perioperative Treatment with the Antineoplastic Agent Taurolidine. European Surgical Research. 42(2). 91–96. 5 indexed citations
12.
Opitz, Isabelle, Hugo C. van der Veen, Nicole Witte, et al.. (2007). Instillation of Taurolidine/Heparin after Laparotomy Reduces Intraperitoneal Tumour Growth in a Colon Cancer Rat Model. European Surgical Research. 39(3). 129–135. 9 indexed citations
13.
Braumann, Chris, Christoph A. Jacobi, Stephan Rogalla, et al.. (2007). The Tumor Suppressive Reagent Taurolidine Inhibits Growth of Malignant Melanoma—a Mouse Model. Journal of Surgical Research. 143(2). 372–378. 17 indexed citations
14.
Ismail, Mahmoud, Peter Henklein, Xiaohua Huang, et al.. (2006). Identification of HIV‐1 Tat peptides for future therapeutic angiogenesis. European Journal Of Haematology. 77(2). 157–165. 7 indexed citations
15.
Braumann, Chris, Hans Guski, Ingolf Schimke, et al.. (2005). Impact of taurolidin and octreotide on liver metastasis and lipid peroxidation after laparoscopy in chemical induced ductal pancreatic cancer. Investigational New Drugs. 23(2). 157–164. 8 indexed citations
16.
Ordemann, J., Conny Höflich, Chris Braumann, J. Hartmann, & C. A. Jacobi. (2005). Einfluss des Pneumoperitoneums auf die Expression von E-Cadherin, CD44v6 und CD54 (ICAM-1) auf HT-29-Kolonkarzinomzellen. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie. 130(5). 405–409. 5 indexed citations
17.
Braumann, Chris, et al.. (2004). Laparoscopic removal of ingested pin penetrating the gastric wall in an immunosuppressed patient. Surgical Endoscopy. 18(5). 870–870. 3 indexed citations
18.
Braumann, Chris, Wolfgang Henke, Christoph A. Jacobi, & Wolfgang Dubiel. (2004). The tumor‐suppressive reagent taurolidine is an inhibitor of protein biosynthesis. International Journal of Cancer. 112(2). 225–230. 22 indexed citations
19.
Braumann, Chris, et al.. (2003). Local and systemic chemotherapy with taurolidine and taurolidine/heparin in colon cancer-bearing rats undergoing laparotomy. Clinical & Experimental Metastasis. 20(5). 387–394. 20 indexed citations
20.
Braumann, Chris, Jürgen Ordemann, Peer Wildbrett, & Christoph A. Jacobi. (2000). Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats. Clinical & Experimental Metastasis. 18(7). 547–552. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guido Grass Breakdown of academic impact, for papers by Kil Yeon Lee Breakdown of academic impact, for papers by Ching‐Chuan Hsieh Breakdown of academic impact, for papers by Cem Terzi Breakdown of academic impact, for papers by Masashi Tsuruta Breakdown of academic impact, for papers by Arnulf Thiede Breakdown of academic impact, for papers by Jianglong Huang Breakdown of academic impact, for papers by İbrahi̇m Koral Önal Breakdown of academic impact, for papers by Hee Seok Moon Breakdown of academic impact, for papers by Francesco Guerra
Rankless by CCL
2026